- Home
- MGIC vs INM Comparison
MGIC vs INM Comparison
Compare MGIC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- INM
- Stock Information
- Founded
- MGIC 1983
- INM 1981
- Country
- MGIC Israel
- INM Canada
- Employees
- MGIC N/A
- INM N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- INM Health Care
- Exchange
- MGIC Nasdaq
- INM Nasdaq
- Market Cap
- MGIC 673.6M
- INM 3.2M
- IPO Year
- MGIC 1991
- INM N/A
- Fundamental
- Price
- MGIC $14.41
- INM $2.30
- Analyst Decision
- MGIC Buy
- INM
- Analyst Count
- MGIC 2
- INM 0
- Target Price
- MGIC $16.00
- INM N/A
- AVG Volume (30 Days)
- MGIC 31.7K
- INM 46.6K
- Earning Date
- MGIC 05-15-2025
- INM 05-13-2025
- Dividend Yield
- MGIC 3.90%
- INM N/A
- EPS Growth
- MGIC N/A
- INM N/A
- EPS
- MGIC 0.75
- INM N/A
- Revenue
- MGIC $552,520,000.00
- INM $4,832,013.00
- Revenue This Year
- MGIC $7.53
- INM N/A
- Revenue Next Year
- MGIC $4.89
- INM N/A
- P/E Ratio
- MGIC $18.53
- INM N/A
- Revenue Growth
- MGIC N/A
- INM N/A
- 52 Week Low
- MGIC $9.51
- INM $1.72
- 52 Week High
- MGIC $14.48
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- MGIC 63.08
- INM 34.09
- Support Level
- MGIC $13.64
- INM $2.70
- Resistance Level
- MGIC $14.25
- INM $3.20
- Average True Range (ATR)
- MGIC 0.27
- INM 0.23
- MACD
- MGIC 0.05
- INM -0.05
- Stochastic Oscillator
- MGIC 95.17
- INM 5.26
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. It generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel; Europe; Japan, and Other countries.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.